Council Focused On Japanese Regs For Quasi-Drugs, Anti-Aging Included

Japan's Ministry of Health, Labor and Welfare vows to keep up discussions with stakeholders - including U.S. industry - on "ways to increase the transparency and efficiency" of its approval process for quasi-drugs, which include anti-aging products

More from Archive

More from HBW Insight